Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B2BY
|
|||
| Former ID |
DIB001256
|
|||
| Drug Name |
TAK-661
|
|||
| Synonyms |
3-(7-Isopropyl[1,2,4]triazolo[1,5-b]pyridazin-6-yloxy)-2,2-dimethylpropanesulfonamide
Click to Show/Hide
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Discontinued in Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H21N5O3S
|
|||
| Canonical SMILES |
CC(C)C1=CC2=NC=NN2N=C1OCC(C)(C)CS(=O)(=O)N
|
|||
| InChI |
1S/C13H21N5O3S/c1-9(2)10-5-11-15-8-16-18(11)17-12(10)21-6-13(3,4)7-22(14,19)20/h5,8-9H,6-7H2,1-4H3,(H2,14,19,20)
|
|||
| InChIKey |
ABSYJOKYMQTMMK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010829) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.